Fidelma Hackett
YOU?
Author Swipe
View article: Twenty Years of Nurse-Led Research in Hemato-Oncology: A Mapping Review
Twenty Years of Nurse-Led Research in Hemato-Oncology: A Mapping Review Open
To support more nurse-led interventional research, strategic investment in mentorship, protected research time, interdisciplinary collaboration, structured clinical-academic posts, and funding pathways is needed.
View article: Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care
Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care Open
Venetoclax, a highly selective, oral B-cell lymphoma 2 inhibitor, provides a robust targeted-therapy option for the treatment of chronic lymphocytic leukemia (CLL), including patients with high-risk del(17p)/mutated-TP53 and immunoglobulin…